Completed
A 2012 IOM report emphasized capacity building in low- and middle-income countries as means to improve global food and drug safety. At the Food and Drug Administration's request, the National Academies has convened a committee to assess how the challenges and opportunities facing regulators have changed since 2012 and to discuss donor aid and regulatory systems' capacity to ensure safety and quality, the lack of post-market surveillance and the challenges of informal markets.